Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, August 26, 2021
[ Thu, Aug 26th 2021
] - WOPRAI
[ Thu, Aug 26th 2021
] - WOPRAI
[ Thu, Aug 26th 2021
] - WOPRAI
[ Thu, Aug 26th 2021
] - WOPRAI
[ Thu, Aug 26th 2021
] - WOPRAI
[ Thu, Aug 26th 2021
] - WOPRAI
[ Thu, Aug 26th 2021
] - WOPRAI
[ Thu, Aug 26th 2021
] - WOPRAI
[ Thu, Aug 26th 2021
] - WOPRAI
[ Thu, Aug 26th 2021
] - WOPRAI
[ Thu, Aug 26th 2021
] - WOPRAI
[ Thu, Aug 26th 2021
] - WOPRAI
[ Thu, Aug 26th 2021
] - WOPRAI
[ Thu, Aug 26th 2021
] - WOPRAI
[ Thu, Aug 26th 2021
] - WOPRAI
[ Thu, Aug 26th 2021
] - WOPRAI
[ Thu, Aug 26th 2021
] - WOPRAI
[ Thu, Aug 26th 2021
] - WOPRAI
[ Thu, Aug 26th 2021
] - WOPRAI
[ Thu, Aug 26th 2021
] - WOPRAI
[ Thu, Aug 26th 2021
] - WOPRAI
[ Thu, Aug 26th 2021
] - WOPRAI
[ Thu, Aug 26th 2021
] - WOPRAI
[ Thu, Aug 26th 2021
] - WOPRAI
[ Thu, Aug 26th 2021
] - WOPRAI
[ Thu, Aug 26th 2021
] - WOPRAI
[ Thu, Aug 26th 2021
] - WOPRAI
[ Thu, Aug 26th 2021
] - WOPRAI
Wed, August 25, 2021
[ Wed, Aug 25th 2021
] - WOPRAI
Kalpit Patel Initiated (VINC) at Strong Buy and Held Target at $26 on, Aug 25th, 2021
Kalpit Patel of B. Riley Securities, Initiated "Vincerx Pharma, Inc." (VINC) at Strong Buy and Held Target at $26 on, Aug 25th, 2021.
Kalpit has made no other calls on VINC in the last 4 months.
There is 1 other peer that has a rating on VINC. Out of the 1 peers that are also analyzing VINC, 0 agree with Kalpit's Rating of Hold.
This is the rating of the analyst that currently disagrees with Kalpit
- Geulah Livshits of "Chardan Capital" Maintained at Strong Buy with Decreased Target to $30 on, Friday, August 13th, 2021
